Growth-independent inhibition of aflatoxin biosynthesis with selected nanoparticles

US12108764B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12108764-B2
Application numberUS-201815911327-A
CountryUS
Kind codeB2
Filing dateMar 5, 2018
Priority dateMar 3, 2017
Publication dateOct 8, 2024
Grant dateOct 8, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for inhibiting fungal secondary metabolisms are described. Secondary metabolisms inhibited by the methods can include those responsible for expression of mycotoxins such as aflatoxin. Methods can include inhibition of aflatoxin production without inhibiting fungal growth by contacting a fungus with a suspension including silver nanoparticles that can include a surface coating. The methods can be utilized in preventing fungal-caused destruction of plant species (e.g., crop species). Disclosed methods encompass utilization of silver nanoparticles at low concentrations of from about 10 picograms per liter to about 1 microgram per liter.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for inhibiting production of an aflatoxin in a fungus comprising: forming a first suspension of silver nanoparticles, the silver nanoparticles comprising a surface coating, the coated silver nanoparticles having an average size of from 15 nanometers to 30 nanometers as determined by transmission electron microscopy; separating the coated silver nanoparticles from the first suspension by ultrafiltration in a diafiltration mode; redispersing the coated silver nanoparticles in a second suspension, the second suspension including the coated silver nanoparticles at a concentration of from 25 nanograms per milliliter to 60 nanograms per milliliter; contacting the fungus with the second suspension, wherein during a period of time in which the fungus is in contact with the suspension, fungal aflatoxin production is inhibited with no significant decrease in fungal growth rate as expressed as dry weight accumulation per unit time of the contact. 2. The method of claim 1 , wherein the fungus comprises a mycotoxin-producing filamentous fungus. 3. The method of claim 1 , wherein the fungus comprises Aspergillus parasiticus. 4. The method of claim 1 , the coated silver nanoparticles having an average size of 20 nanometers. 5. The method of claim 1 , wherein the coating comprises a citrate. 6. The method of claim 1 , wherein the coating comprises a polymer. 7. The method of claim 1 , the method decreasing generation of reactive oxygen species by the fungus during the period of time of contact. 8. The method of claim 1 , the method inhibiting transcription of one or more genes associated with aflatoxin biosynthesis during the period of time of contact. 9. The method of claim 1 , the method inhibiting the global regulators of secondary metabolism laeA and veA during the period of time of contact. 10. The method of claim 1 , the second suspension including the coated silver nanoparticles at a concentration of 50 nanograms per milliliter. 11. The method of claim 6 , wherein the coating comprises polyvinyl pyrrolidone. 12. The method of claim 1 , wherein the second suspension includes the coated silver nanoparticles at a concentration of from 40 nanograms per milliliter to 60 nanograms per milliliter. 13. The method of claim 1 , wherein the second suspension includes the coated silver nanoparticles at a concentration of 25 nanograms per milliliter.

Assignees

Inventors

Classifications

  • Microcapsules {or nanocapsules} · CPC title

  • A01N59/16Primary

    Heavy metals; Compounds thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12108764B2 cover?
Methods for inhibiting fungal secondary metabolisms are described. Secondary metabolisms inhibited by the methods can include those responsible for expression of mycotoxins such as aflatoxin. Methods can include inhibition of aflatoxin production without inhibiting fungal growth by contacting a fungus with a suspension including silver nanoparticles that can include a surface coating. The metho…
Who is the assignee on this patent?
Univ South Carolina
What technology area does this patent fall under?
Primary CPC classification A01N59/16. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).